BCKDK gene mutations as a rare condition responsible for comorbid neurodevelopmental delay, autism, and epilepsy: a case series of four patients
Open Access
- 16 June 2025
- journal article
- case report
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (7) , 4046-4052
Abstract
Introduction: Mutations in the branched-chain keto-acid dehydrogenase kinase gene (BCKDK), leading to low plasma branched-chain amino acids (BCAAs) levels, have been reported as a contributor to comorbid intellectual disability, autism, epilepsy, and neurodevelopmental delay (NDD). Due to the rarity of knowledge about these mutations, the current case series aims to introduce four confirmed cases. Methods: This case series study analyzed children from a neurometabolic clinic. Social and adaptive functions were assessed using the vineland social maturity scale (VSMS). Whole exome sequencing (WES) identified genetic variants filtered using population databases. Candidate variants were confirmed through Sanger sequencing and interpreted based on ACMG guidelines. Results: Four children of unrelated consanguineous families suffering from global NDD and autism were referred to our center. Neuroimaging assessments revealed negligible findings; thus, metabolic tests were sent, in which BCAAs were lower than normal limits. Therefore, genetic testing was done, and genetic variants compatible with BCKDK deficiency were detected. By initiating a BCAAs-rich regimen, the patients had significant improvements in psychomotor and speech development. Conclusion: The diagnosis of BCKDK deficiency should be suspected in patients with NDD and autism, and BCAA supplementation should be initiated as soon as diagnosis confirmation to prevent irreversible brain damage. The results emphasize that early diagnosis and dietary intervention by regulating plasma BCAA levels lead to the prevention of irreversible neurodevelopmental implications.Keywords
This publication has 24 references indexed in Scilit:
- The Metabolic Treatabolome and Inborn Errors of Metabolism Knowledgebase therapy tool: Do not miss the opportunity to treat!Journal of Inherited Metabolic Disease, 2025
- The role of BCAA metabolism in metabolic health and diseaseExperimental & Molecular Medicine, 2024
- Brief Report: Delayed Diagnosis of Treatable Inborn Errors of Metabolism in Children with Autism and Other Neurodevelopmental DisordersJournal of Autism and Developmental Disorders, 2020
- Branched-Chain Amino Acids and Brain MetabolismNeurochemical Research, 2017
- Dataset reporting BCKDK interference in a BCAA-catabolism restricted environmentData in Brief, 2016
- Mitochondrial response to the BCKDK-deficiency: Some clues to understand the positive dietary response in this form of autismBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2016
- Two Novel Mutations in theBCKDK(Branched-Chain Keto-Acid Dehydrogenase Kinase) Gene Are Responsible for a Neurobehavioral Deficit in Two Pediatric Unrelated PatientsHuman Mutation, 2014
- A Novel Regulatory Defect in the Branched-Chain α-Keto Acid Dehydrogenase Complex Due to a Mutation in thePPM1KGene Causes a Mild Variant Phenotype of Maple Syrup Urine DiseaseHuman Mutation, 2012
- Autistic Traits and Cognitive Performance in Young People with Mild Intellectual ImpairmentJournal of Autism and Developmental Disorders, 2007
- Brain metabolism of branched-chain amino acidsGlia, 1997